The article also discusses the potential of AI-enabled personalization in contraception, which could help predict individual responses to contraceptives and optimize outcomes while minimizing side effects. Dama Health is mentioned as a company developing AI-driven clinical software for this purpose. The article also touches on the development of male contraceptives, including hormonal formulations and nonhormonal implants. It concludes by emphasizing the importance of high-quality data, industry partnerships, and investment in the field to expedite progress and access to these innovative contraceptive solutions.
Key takeaways:
- New methods of contraception are being developed, including a radically new approach using monoclonal antibodies to prevent pregnancy and a contraceptive product that reinforces the natural cervical mucus barrier.
- Improvements in contraceptive delivery are being made, such as a suction-based cervical tool to reduce pain during procedures and a biodegradable implant that releases progestin steadily.
- AI-driven personalization of contraception is a promising area of innovation, with companies like Dama Health developing clinical software that matches patients to the most personalized contraception method for them.
- Male contraception is an area of research with potential to increase gender equity, with hormonal formulations and nonhormonal contraception implants for men being developed.